Delivery Order SPE2DE22D0008-SPE2D625F2NJU
- Not listed
- Alba Bioscience, Inc. was awarded a delivery order contract by the Defense Logistics Agency's Medical Supply Chain division on August 14, 2025, for the supply of ALBACLONE Anti-D Blend, a specialized blood bank reagent used in immunohematology testing. This firm fixed-price contract carries a ceiling value of $1,464.00 with an ultimate completion date of August 19, 2025. The contract was awarded on a non-competitive basis with no set-aside designation, reflecting Alba Bioscience's established...
- Alba Bioscience, Inc. was awarded a delivery order valued at $6,270 on September 4, 2025, for the ALBACYTE Antibody ID Panel (10-Cell) under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain division. The contract is scheduled for completion by November 7, 2025, and will be performed at the contractor's facility in Chicago, Illinois. This non-set-aside award represents Alba Bioscience's continued role as a critical supplier of specialized in vitro diagnostic...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $2,832.45 to Alba Bioscience, Inc., a foreign-owned, for-profit organization specializing in in vitro diagnostics and blood banking products. The contract, identified as SPE2DE22D0008|SPE2D625F17Y7, is for the delivery of ALBACLONE anti-FYB medical supplies by December 2, 2024. This award is not designated as a set-aside contract. Alba Bioscience is a subsidiary of...
- This is a federal contract award to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various U.S. government agencies. The contract, valued at $4,886.95, is a delivery order issued by the Defense Logistics Agency Troop Support Medical for the supply of ALBACLONE Anti-S (Big S) blood bank products. The contract has a firm fixed-price pricing type and...
- This is a federal contract award to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials. The contract is a Delivery Order worth $4,740.00 for ALBACLONE Anti-A products, awarded by the Defense Logistics Agency (DLA), which supports the Department of Defense and other federal healthcare systems. The contract has a firm fixed-price pricing type and an ultimate completion date of July...
- This contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order for $14,457.00 with Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various U.S. government agencies. The contract is for the delivery of ALBACLONE Anti-A products and has a completion date of September 5, 2024. This contract is not designated as a set-aside. Alba...
- This is a delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain division to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various U.S. government agencies. The contract, valued at $10,683.00, is for the delivery of ALBACYTE antibody identification panels and is a firm fixed-price agreement with a completion date...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a subsidiary of Quotient Biodiagnostics, Inc. The contract is for the delivery of ALBACYTE antibody identification panels, which are in vitro diagnostic products used in blood banking operations across various government agencies, including the Department of Veterans Affairs (VA), Defense Health Agency (DHA), and National Institutes of Health (NIH). The contract is a Delivery Order with a Firm...
- This federal contract award to Alba Bioscience, Inc., a foreign-owned for-profit organization, is for the supply of specialized in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials. The contract, valued at $6,750.00, was awarded by the Defense Logistics Agency (DLA) Medical Supply Chain division to support defense medical operations. The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV), likely a Blanket Purchase Agreement...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various federal agencies. The contract, valued at $2,370.00, is for the delivery of ALBACLONE anti-B products. The award is not associated with a set-aside program and is a Firm Fixed Price Delivery Order contract type. Alba...
- SPE2DE22D0008Indefinite Delivery Contract
- SPE2DE22D0008-SPE2D625F2NJUDelivery Order
The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a delivery order contract to Alba Bioscience, Inc. for ALBACLONE anti-FYB antibody screening products. The contract, valued at $12,875 with a firm fixed price structure, was executed on September 4, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside award represents a continuation of Alba Bioscience's established role as a critical supplier of specialized in vitro diagnostic reagents and blood banking products to federal healthcare systems. Performance will be completed at the company's facility in Chicago, Illinois. Alba Bioscience, Inc., a foreign-owned subsidiary of Quotient Biodiagnostics, Inc., specializes in the production and distribution of blood bank reagents, antibody screening tests, and quality control materials for military and federal medical facilities. The company maintains significant indefinite delivery vehicle relationships with the Department of Veterans Affairs through two Blanket Purchase Agreements valued at $199,671.75 and $109,420.35, which facilitate ongoing procurement of blood banking supplies across the VA's integrated healthcare system. Alba Bioscience's contract history demonstrates consistent competitive success in providing highly specialized immunohematology products, with delivery orders and purchase orders typically ranging from modest unit orders to comprehensive packages exceeding $383,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.9k | 9/4/25 |